The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2020 | Latest news in cellular therapies
Christian Chabannon, MD, PhD, Aix Marseille Universit (AMU) School of Medicine, Marseille, France, talks on some of the exciting innovative cellular therapies in development including Zynteglo, a gene-therapy approved in Europe for the treatment of beta thalassemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Disclosures
Sanofi SA, Kite / Gilead, Novartis, Celgene / BMS, Janssen, Bellicum Pharmaceuticals, Terumo BCT: speakers bureau & advisory boards
